LSE - Delayed Quote USD

DaVita Inc. (0I7E.L)

137.57

-1.43

(-1.03%)

At close: May 23 at 5:09:08 PM GMT+1

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

DaVita Inc. (NYSE: DVA) ("DaVita") announced today the upsize and pricing of its previously announced private offering (the "offering") of its 6.750% senior notes due 2033 (the "2033 notes"). The aggregate principal amount of the 2033 notes offered in the offering was increased from $750 million to $1 billion, and the 2033 notes were priced at 100.000% of their face amount to yield a 6.750% coupon. The offering is expected to close on May 23, 2025, subject to satisfaction of customary closing co

PR Newswire 4 days ago

DVA
DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

Today, DaVita (NYSE: DVA) published its Community Care report, underpinning its long-standing commitment to corporate citizenship and highlighting strides made towards ambitious Environmental, Social and Governance (ESG) goals set to be achieved this year. Milestones and achievements reflect calendar year 2024.

PR Newswire 4 days ago

DVA
DaVita Inc. Announces Offering of $750 Million Senior Notes

DaVita Inc. (NYSE: DVA) ("DaVita") announced today that it has commenced a private offering (the "offering") of $750 million aggregate principal amount of its senior notes due 2033 (the "2033 notes"), subject to market and other conditions.

PR Newswire 4 days ago

DVA
Warren Buffett Sells $168M in DaVita Inc. (DVA) Shares

According to a Form 4 filing with the United States Securities and Exchange Commission, on May 8, Berkshire Hathaway sold 1,145,938 shares of DaVita Inc. (NYSE:DVA), valued at $168.58 million. The move occurred just a day before a union health benefits fund sued top dialysis services providers in the country, including DaVita Inc. (NYSE:DVA), for […]

Insider Monkey 7 days ago

DVA
Here's Why DaVita HealthCare (DVA) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks 9 days ago

DVA
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks 10 days ago

DVA
DaVita Inc. (DVA): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying

We recently published a list of 15 Small-Cap Healthcare Stocks Hedge Funds Are Buying. In this article, we are going to take a look at where DaVita Inc. (NYSE:DVA) stands against other small-cap healthcare stocks hedge funds are buying. The U.S. healthcare sector has performed better in 2025 compared to the broader market. After two […]

Insider Monkey 10 days ago

DVA
DaVita First Quarter 2025 Earnings: EPS Beats Expectations

DaVita ( NYSE:DVA ) First Quarter 2025 Results Key Financial Results Revenue: US$3.22b (up 5.0% from 1Q 2024). Net...

Simply Wall St. 11 days ago

DVA
DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract

Strength in revenue per treatment and dialysis patient service revenues drives DVA's first-quarter 2025 performance despite a year-over-year decline in normalized non-acquired treatment.

Zacks 11 days ago

DVA

BSX

ITGR
Q1 2025 DaVita Inc Earnings Call

Q1 2025 DaVita Inc Earnings Call

Thomson Reuters StreetEvents 11 days ago

DVA
DaVita Inc (DVA) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Resilience

Despite operational hurdles, DaVita Inc (DVA) showcases strong financial management and strategic initiatives to drive future growth.

GuruFocus.com 12 days ago

DVA
DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates

DaVita HealthCare (DVA) delivered earnings and revenue surprises of 14.29% and 0.38%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 12 days ago

DVA
DaVita (NYSE:DVA) Beats Q1 Sales Targets

Dialysis provider DaVita Inc. (NYSE:DVA) announced better-than-expected revenue in Q1 CY2025, with sales up 5% year on year to $3.22 billion. Its non-GAAP profit of $2 per share was 1% below analysts’ consensus estimates.

StockStory 12 days ago

DVA
DaVita First-Quarter 2025 Financial Results: Just the Numbers

Kidney treatment company DaVita on Monday afternoon reported first-quarter 2025 financial results.

Investopedia 12 days ago

DVA
DaVita HealthCare: Q1 Earnings Snapshot

DENVER (AP) — DaVita HealthCare Partners Inc. DVA) on Monday reported earnings of $162.9 million in its first quarter. On a per-share basis, the Denver-based company said it had profit of $2.

Associated Press Finance 12 days ago

DVA
DaVita Inc. 1st Quarter 2025 Results

DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2025.

PR Newswire 12 days ago

DVA
DaVita (DVA) Reports Earnings Tomorrow: What To Expect

Dialysis provider DaVita Inc. (NYSE:DVA) will be announcing earnings results tomorrow afternoon. Here’s what investors should know.

StockStory 14 days ago

DVA
3 Healthcare Stocks in Hot Water

Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 13.3%. This drawdown was worse than the S&P 500’s 5.8% fall.

StockStory 16 days ago

DVA

WST

CELG-RT
Astrana Health, Inc. (ASTH) Q1 Earnings and Revenues Lag Estimates

Astrana Health, Inc. (ASTH) delivered earnings and revenue surprises of -39.13% and 2.33%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 16 days ago

DVA
A Second Chance at a Second Chance: Rick Searches for a Kidney Transplant

NORTHAMPTON, MA / ACCESS Newswire / May 8, 2025 / For more than a decade, Rick Mendoza had been fully enjoying his kidney transplant. From hikes to mowing the lawn to attending his daughter's school and sporting events, his transplant let him experience ...

ACCESS Newswire 16 days ago

DVA

Performance Overview

Return	0I7E.L	MSCI WORLD (^990100-USD-STRD)
YTD	-8.73%	+2.56%
1-Year	-0.04%	+9.84%
3-Year	+48.94%	+40.84%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

DaVita Inc. (0I7E.L)

DaVita Inc. Announces Upsize and Pricing of $1 Billion Senior Notes Offering

DaVita Releases Annual Community Care Report, Highlights Achievements in Corporate Citizenship

DaVita Inc. Announces Offering of $750 Million Senior Notes

Warren Buffett Sells $168M in DaVita Inc. (DVA) Shares

Here's Why DaVita HealthCare (DVA) is a Strong Growth Stock

Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term

DaVita Inc. (DVA): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying

DaVita First Quarter 2025 Earnings: EPS Beats Expectations

DaVita Stock Down Despite Q1 Earnings Beat, Margins Contract

Q1 2025 DaVita Inc Earnings Call

DaVita Inc (DVA) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Resilience

DaVita HealthCare (DVA) Q1 Earnings and Revenues Beat Estimates

DaVita (NYSE:DVA) Beats Q1 Sales Targets

DaVita First-Quarter 2025 Financial Results: Just the Numbers

DaVita HealthCare: Q1 Earnings Snapshot

DaVita Inc. 1st Quarter 2025 Results

DaVita (DVA) Reports Earnings Tomorrow: What To Expect

3 Healthcare Stocks in Hot Water

Astrana Health, Inc. (ASTH) Q1 Earnings and Revenues Lag Estimates

A Second Chance at a Second Chance: Rick Searches for a Kidney Transplant

Performance Overview